11/19
08:30 am
hcwb
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
High
Report
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
11/18
07:25 am
hcwb
HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease
High
Report
HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease
11/14
05:41 pm
hcwb
HCW Biologics GAAP EPS of -$2.02, revenue of $15.60M [Seeking Alpha]
High
Report
HCW Biologics GAAP EPS of -$2.02, revenue of $15.60M [Seeking Alpha]
11/14
04:44 pm
hcwb
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results
High
Report
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results
11/10
07:00 am
hcwb
HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer
Low
Report
HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer
11/7
07:00 am
hcwb
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
High
Report
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
10/22
09:00 am
hcwb
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment
Low
Report
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment
10/16
09:55 am
hcwb
HCW Biologics to Participate in the 2025 Maxim Growth Summit [Yahoo! Finance]
Medium
Report
HCW Biologics to Participate in the 2025 Maxim Growth Summit [Yahoo! Finance]
10/16
09:25 am
hcwb
HCW Biologics to Participate in the 2025 Maxim Growth Summit
Medium
Report
HCW Biologics to Participate in the 2025 Maxim Growth Summit
10/16
09:15 am
hcwb
HCW Biologics’ Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer
Medium
Report
HCW Biologics’ Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer
9/30
08:45 am
hcwb
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment About its Proprietary T-Cell Engager Program
Medium
Report
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment About its Proprietary T-Cell Engager Program
9/18
09:29 am
hcwb
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics [Globe and Mail, The (Toronto, Canada)]
Low
Report
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics [Globe and Mail, The (Toronto, Canada)]
9/18
09:24 am
hcwb
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing [Yahoo! Finance]
Low
Report
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing [Yahoo! Finance]
9/18
09:15 am
hcwb
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing
Low
Report
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing
9/18
09:10 am
hcwb
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics
Medium
Report
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics
9/18
09:10 am
hcwb
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics
Medium
Report
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics
9/9
08:28 am
hcwb
HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program [Yahoo! Finance]
Medium
Report
HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program [Yahoo! Finance]
9/9
08:00 am
hcwb
HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program
High
Report
HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program